Approval Mechanism for Suppliers of Malaria Drugs and Nets Presentation by Dr Maryse Dugué RBM Partnership Secretariat, Malaria Medicines & Supplies Services.

Slides:



Advertisements
Similar presentations
Realities in the field FEVER Differential Diagnosis not possible What happens in practice when a child presents with fever Where malaria risk is high.
Advertisements

Quality Assurance Processes for TB Drugs. GDF Quality Assurance Processes.
Prequalification of HIV/AIDS Drugs - UN joint activity lPartners* –UNAIDS –UNICEF –UNFPA –WHO –With the support of World Bank lWHO –Manages, provides technical.
Malaria Medicines & Supplies Services (MMSS) Presentation by Rémy Prohom RBM Partnership Secretariat, Malaria Medicines & Supplies Services Copenhagen.
WHO update on: Guidelines for the selection of RH medicines and prequalification of priority RH medicines Medicines Policy and Standards Health Technology.
Malaria treatment (Current WHO recommendations & guidelines)
Prequalification and Quality Monitoring of anti-malaria products Andre van Zyl, M. Pharm. Project Manager Health Technology and Pharmaceuticals Cluster,
WHO Training Course on Prequalification Introduction Efficacy and Safety Issues Hans Kemmler Consultant to WHO Accra, 5.Nov
UNICEF Medicines Supply Strengthening WHO Technical Briefing Seminar on Essential Medicines and Health Products Tuesday 29 October 2013 Technical Specialist.
Slide 1 of 19D.K. Mubangizi, Dar Es Salaam Sept Training Workshop for Evaluators from National Medicines Regulatory Authorities in East African Community.
IPC meeting June 2014 Dr Joelle DAVIAUD, Quality Assurance Specialist Model Quality Assurance System for procurement agencies.
World Health Organization
Malaria medicines and diagnostics WHO/UNICEF TBS Access to medicines 19 November Geneva Silvia Schwarte Global Malaria Programme.
Choice of antimalarial drugs Malaria Medicines & Supplies Services RBM Partnership Secretariat.
TANZANIA August Note on Choice of Comparator Products: Current status Note to Applicants on Choice of Comparator Products in the Prequalification.
TBS Meeting Geneva, November 2011 Global Fund Policies and Reporting on Procurement of Health Products WHO/UNICEF Technical Briefing Seminar on Essential.
1 Procurement of ACT's Informal Workshop on Prequalification of Antimalarial Drug Products Geneva, 5 th May 2004 WHO/UNICEF JOINT REQUEST FOR PROPOSALS.
WHO Projects Organized in Cooperation with SFDA in China Christina Foerg-Wimmer, PhD Pharmaceutical Advisor WHO China Office May 18, 2011 | Beijing, China.
PREQUALIFICATION General overview and procedures Maija Hietava M.Sci.Pharm Quality Assurance and Safety: Medicines, Medicines Policy and Standards, Health.
PREQUALIFICATION General overview and procedures
NATIONAL DRUG AUTHORITY - UGANDA | Slide 1 of February 2010, Geneva, Switzerland How the African NMRAs are benefiting from the WHO medicines prequalification.
WHO Prequalification – Medicines Finished Pharmaceutical Products Hua YIN
Update on prequalification of essential medicines for reproductive health Dr Hans V. Hogerzeil Director Medicines Policy and Standards WHO, Geneva Reproductive.
UN Prequalification Programme
Update and future directions for prequalification of medicines WHO HQ, Geneva, 4 February 2008 Dr Lembit Rägo Coordinator Quality Assurance and Safety:
Antimalarial Medicines: Current Status in Africa Dr Clive Ondari Medicines Policy and Standard Department WHO/HQ.
INDEPTH Effectiveness and Safety studies of antimalarials in Africa (INESS ) IMPLEMENTATION SO FAR Aziza Mwisongo INDEPTH AGM PUNE, INDIA October 2009.
QUALITY REPRODUCTIVE HEALTH SUPPLIES Dr Hans V. Hogerzeil Director Essential Medicines & Pharmaceutical Policies.
The PAHO Prequalification System External Quality Control Program of Official Drug Quality Control Laboratories (EQCP) José M. Parisi PAHO/WHO Costa Rica.
RHSC Meeting Kampala, May 2010 Quality for Medicines The Global Fund approach Sophie Logez Manager, QA and Data Quality Pharmaceutical Management.
Artemisinin combined medicines, Kampala, February |1 | Training workshop on regulatory requirements for registration of Artemisinin based combined.
Access to Artemisinin-Based Antimalarial Products Dr Clive O Ondari Essential Drugs and Medicines Policy Dept & Roll Back Malaria (RBM) Department World.
UN / WHO Prequalification Programme for Priority Medicines
1 WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies Tuesday 1 November 2011 Technical Specialist Henrik K.Nielsen, Medicines and Nutrition.
Slide 1 of 10D.K. Mubangizi, Dar Es Salaam Sept Training Workshop for Evaluators from National Medicines Regulatory Authorities in East African Community.
Ensuring Access to Antimalarial Drugs Dr Clive O Ondari Essential Drugs and Medicines Policy Dept. World Health Organization October 2002.
PQP-overview & update January Prequalification of Medicines Overview & update Wondiyfraw Z. Worku WHO Prequalification of Medicines Programme Assessment.
WHO Prequalification of Medicines Programme Raul Kiivet, MD, PhD Manager, Prequalification of Medicines Programme Quality Assurance and Safety: Medicines.
WHO Workshop on Assessment of Bioequivalence Data Addis Ababa, 31. August – 3. September 2010 Selection of comparators Compiled by Jan Welink WHO Workshop.
Pogány - Tanzania 1/36 WHO Training Workshop on Pharmaceutical Quality, GMP and Bioequivalence János Pogány, pharmacist, PhD consultant to.
WHO Prequalification of Medicines: a gateway to the global pharmaceutical market Introduction 28 June 2014, Shanghai Milan Smid.
WHO Prequalification Programme Milan Smid, M.D., Ph.D. Prequalification Programme: Priority Essential Medicines.
UNICEF Medicines Supply Strengthening WHO/UNICEF Technical Briefing Seminar on Essential Medicines Policies Tuesday 30 October 2012 Technical Specialist.
Next-Generation LLINs: Programmatic Implications Matthew Lynch October 26, 2015.
TANZANIA AUGUST TRAINING WORKSHOP ON PHARMACEUTICAL QUALITY, GOOD MANUFACTURING PRACTICE AND BIOEQUIVALENCE WITH A FOCUS ON ARTEMISININS.
| Slide 1 of 34 April 2007 Training Workshop on Pharmaceutical Development with focus on Paediatric Formulations Protea Hotel Victoria Junction, Waterfront.
Deficiencies in Bioequivalence dossiers Overview and Examples.
Achievements and impacts of WHO prequalification to date MSF perspective Carine Werder MSF international pharmacist coordinator Geneva, 11 th February.
Key Issues from DAY 2 31 st January 2006 Jane Masiga & Val Remedios.
The WHO Prequalification of Medicines Program - Introduction Tony Gould Manager, Prequalification of Medicines Program WHO.
Dr. Pogány - Geneva 1/30 PREQUALIFICATION OF ANTIMALARIAL DRUG PRODUCTS János Pogány, pharmacist, Ph.D. Geneva, 03 May 2004
3rd WHO Prequalification Stakeholders Meeting :Diagnostics 3rd Stakeholders Meeting on Prequalification Geneva, 4th February 2008 Update on Prequalification.
1 CHALLENGES IN REGULATING QUALITY AND RATIONAL USE OF ANTIBIOTICS ALLIANCE FOR THE PRUDENT USE OF ANTIBIOTICS: INAGURAL MEETING COURTYARD.
1 |1 | WHO Prequalification – Medicines Assessments Andrew Chemwolo, Technical Officer Prequalification Team – Medicines Assessment.
Ensuring quality of medicines procured with Global Fund resources HIV AIDS conference Satellite on Essential Medicines for HIV AIDS Mexico 6 August 2008.
Access to Antimalarial Medicines EDM-RBM Collaboration
Prequalification of essential medicines
Update on prequalification of medicines
Malaria Programmes and Implication on Strengthening the overall Health System Presentation by Dr Maryse Dugué RBM Partnership Secretariat, Malaria Medicines.
Establishing Quality Product Supply of Chlorhexidine for Umbilical Cord Care through Local Production Global Maternal Newborn Health Conference October.
Access to Antimalarial Medicines
Overview of vaccines prequalification
GDF Quality Assurance Processes
World Health Organization
Access to Artemisinin-based Antimalarial Medicines
Quality Problems with Antimalarials
Prequalification of essential medicines
Global Drug Facility: Providing Access to Medicines and Commodities for Tuberculosis Thomas Moore Manager GDF Geneva, 19 November 2009.
Malaria Medicines & Supplies Services RBM Partnership Secretariat
Prequalification of HIV/AIDS products and manufacturers
Presentation transcript:

Approval Mechanism for Suppliers of Malaria Drugs and Nets Presentation by Dr Maryse Dugué RBM Partnership Secretariat, Malaria Medicines & Supplies Services Copenhagen – 310 January

Mechanisms 2 different mechanisms: Prequalification for drugs WHOPES testing of pesticides for public health

Pre-qualification of Drugs Manufacturers & Products Issues: a considerable number of sub- standard products and counterfeit anti- malarials Objectives: –To accelerate sustained access to, and use of, good quality ACTs –To ensure that adequate and effective treatment reaches significantly greater numbers of people in need –To assist/support the implementation of ACTs in ways that respond to the specific needs and requests of individual countries –To support drug regulatory agencies in regulating ACTs

Expression of Interest (EOI) - Artemisinin- based ACTs –Products selected: Artesunate (oral preparations, rectal prep.) Dihydroartemisinin (tablets, capsules, granules, suppositories) Artemether (oral preparations) Artemether/lumefantrine (oral preparations) Artesunate + amodiaquine (oral preparations) Artesunate + mefloquine (oral preparations) Artesunate (injection for IV and IM) Artemotil (injection forms) Artesunate + sulphadoxine/pyrimethamine (oral preparations) Pre-qualification of Drugs Manufacturers & Products

Multi-source combination antimalarial drug products - in majority of cases not typical “generic” drugs Usually generic drugs “well established” … –ACTs are relatively new, or very new drugs –Limited information available in public domain Most ACTs do not have quality standards For most ACTs reference standards not readily available –Reference standards available only for those that have pharmacopoeial monographs Difficulties of proving “interchangeability” Regulators have limited experience with this group of drugs...

Processes of Pre-qualification of manufacturers (of artemisinin-based combination antimalarial drug products) –Preparatory Phase Drafting of specifications and guidelines (products and product files) Publication of Expression of Interest (EOI) - IHT and WWW –Documentation Review Phase Receiving of EOI (letter+files) Screening, assessing, and reviewing dossiers  Report ……… Pre-qualification of Drugs Manufacturers & Products

Processes of Pre-qualification of manufacturers (of artemisinin-based combination antimalarial drug products) –Plant Inspection (GMP compliance) Phase Team of inspectors appointed by QSM/EDM Inspections carried out jointly with respective DRA –Reporting Phase Results in a “white” list of products and manufacturers. Pre-qualification of Drugs Manufacturers & Products

Assessment of dossiers –Carried out by teams of professionals from national DRAs (mix of developed and developing countries) Manufacturing sites inspections –Carried out by teams of three: WHO representative (qualified GMP inspector), inspector from well established inspectorate (PIC/S countries) and national inspector(s) Qualified inspectors pool limited, no additional capacities Pre-qualification of Drugs Manufacturers & Products

Issues with Prequalification of anti-malarials Status: so far only one combination prequalified: artemether/lumefantrine (Novartis) Several good candidates for artesunate+amodiaquine Need additional mechanism to make good quality formulations available to countries: joint tender WHO/UNICEF

Access to ACTs of Good Quality List of products/manufacturers evaluated as complying with GMP and other quality requirements Items included in the WHO WebBuy and UNICEF Supply Division catalogue List available on MMSS website:

Insecticides Treated Nets & quality assurance WHOPES collects, consolidates, evaluates and disseminates information on the use of pesticides for public health. Its recommendations facilitate the registration of pesticides by Member States. WHOPES is NOT a registration authority But: a product IS or IS NOT regarded as a LLIN after WHOPES evaluation PermaNet® 2.0 and Olyset Net® are currently the only LLINs recommended by WHO for malaria prevention and control

Quality control of nets Specifications have been developed only for polyester netting's and Olyset LLINs: resist more than 50 ISO normalized washes at 60°C Additional work on specifications ongoing (meeting in December 2005) Provisional QC procedure available

WHOPES testing/evaluation of long- lasting insecticidal mosquito nets PhaseType of StudyActivities Phase ILaboratoryRegeneration of insecticide and wash resistance Efficacy Phase IISmall-scale field trials Impact on vector behaviour Efficacy under different ecological settings Safety observations Phase IIIMedium- and/or large-scale field trials Long-lasting efficacy Community acceptance Safety observations

How to contact us… Malaria Medicines & Supply Services (MMSS) Roll Back Malaria Partnership Secretariat Website: Dr Maryse Dugué Manager Tel: +41 (0)